H. Chtioui

Discipline

Psychologie (6) Education (1) Economies et finances (1)

Type de document

Articles (18) Colloques et conférences (3) Recensions (2)

Co-auteur

Date

Source

Mot-clé

Treatment (11) Human beings (9) puits (7) temps (durée) (7) Time (7) Blood (6) thérapie (5) Case (5) Therapeutics (5) Patients (5) Months (5) Liver (5) Grammar, Comparative and general--Case (5) Case (5) Patients (5) plasma (5) toxicité (4) surveillance (4) comparaison (4) Monitoring (4) Comparison (4) Management (4) Example (4) Cannabis (4) Toxicology (4) administration (3) tendance (3) tabagisme (3) sécurité (3) pharmacocinétique (3)

Documents écrit par H. Chtioui (21) | parle de H. Chtioui (0)

Elevated liver function tests in a patient with breast cancer.
C. Neftel et al.
An innovative ethosuximide granule formulation designed for pediatric use: Comparative pharmacokinetics, safety, tolerability, and palatability profile versus reference syrup.
L. Diezi et al.
Optimized LC-MS/MS quantification of tuberculosis drug candidate macozinone (PBTZ169), its dearomatized Meisenheimer Complex and other metabolites, in human plasma and urine.
V. Desfontaine et al. (15 janv. 2023)
Estimating glomerular filtration rate from serum creatinine concentration in children with augmented renal clearance: all formulas are equivocal, but some are more equivocal than others.
P. André et al.
Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events.
A. Coukos et al.
Métabolisme et suivi thérapeutique de l’azathioprine en gastroentérologie et hépatologie [Metabolism and therapeutic monitoring of azathioprine in gastroenterology and hepatology]
D. Bianchetti et al. (31 août 2022)
Quantification of serotonin and eight of its metabolites in plasma of healthy volunteers by mass spectrometry.
P.J. Eugster et al. (10 août 2022)
Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer.
P. Courlet et al. (21 juin 2022)
Development of an assay by liquid chromatography coupled to tandem mass spectrometry for thiopurines drugs in whole blood and application for their Therapeutic Drug Monitoring
N. Nguyen et al. (1 juin 2022)
Pharmacovigilance - Vaccins à ARNm contre le Covid-19 : le point sur les effets indésirables [Pharmacovigilance - mRNA COVID-19 vaccines : current state of knowledge on their adverse effects]
V. Favre et al. (2 févr. 2022)
Iberogast®-Induced Acute Liver Injury—A Case Report
A. Leroy et al. (2022)
Hepatocellular type II fibrinogen inclusions in a patient with severe COVID-19 and hepatitis.
M. Fraga et al.
Combined immune checkpoint inhibitor therapy with nivolumab and ipilimumab causing acute-onset type 1 diabetes mellitus following a single administration: two case reports.
M. Zezza et al. (23 déc. 2019)
Sofosbuvir add-on to ribavirin for chronic hepatitis E in a cirrhotic liver transplant recipient: a case report.
M. Fraga et al. (24 mai 2019)
Rapid Remission of Graves' Hyperthyroidism Without Thionamides Under Immunosuppressive Treatment for Concomitant Autoimmune Hepatitis.
G.E. Papadakis et al.
Sofosbuvir and ribavirin before liver re-transplantation for graft failure due to recurrent hepatitis C: a case report.
J. Vionnet et al. (2015)
Long-term effects of cannabis on brain structure.
G. Battistella et al.
Intravenous streptomycin dosing regimen in a patient undergoing hemodialysis: Plasma level monitoring and pharmacokinetic simulation
H. Chtioui et al.
Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint.
M. Fabritius et al. (2013)
Weed or wheel! FMRI, behavioural, and toxicological investigations of how cannabis smoking affects skills necessary for driving.
G. Battistella et al.
Impact of cannabis inhalation on driving skills in occasional smokers
A. Thomas et al. (2010)